|
|
monoclonal antibody CC49-delta CH2 A humanized CH2 domain-deleted second-generation monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms: | | MOAB HCC49DCH2 MoAb HuCC49DeltaCH2 Monoclonal Antibody HCC49DCH2 | | | Abbreviation: | | MOAB CC49-deltaCH2 | | |
|
|